Polymorphisms, which are variations in DNA sequences among individuals, can significantly influence drug toxicity. Variants in drug-metabolizing enzymes, transporters, and receptors can lead to altered pharmacokinetics and dynamics, resulting in either increased toxicity or therapeutic failure. Understanding these genetic polymorphisms is essential for predicting individual drug responses and avoiding adverse effects.
